By contrast, IDH wild-type gliomas and brain metastases exhibit a more heterogeneous immune landscape that includes a significant presence of monocyte-derived macrophages, neutrophils, and adaptive immune cells, leading to more complex immune interactions [26,27]. The gene discussed is IDH2; the disease is central nervous system cancer.